LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
the launch of the TrueLok™ Hexapod System, or TL-HEX, through its
international orthopedic distribution network. This external hexapod
ring-type fixator for deformity correction and complex trauma treatment
represents the next step in the evolution of the Company's TrueLok™
circular fixation platform. The multi-planar System together with the
associated software provides access to the largest segment of the
circular and hybrid fixation markets that are dominated by one product.
TL-HEX and its software were co-developed with the Company's partner
Texas Scottish Rite Hospital for Children (TSRHC). This partnership was
recently extended through 2028 and has yielded one of Orthofix's most
successful orthopedic products.
President and Chief Executive Officer Robert Vaters said, "As a global
leader in external fixation, Orthofix is very excited to initiate its
international launch of TL-HEX, which truly improves the lives of
patients who are suffering from orthopedic deformities or from trauma.
With our partners at the Texas Scottish Rite Hospital for Children, we
stay committed to the research and development of future ground breaking
external fixation technology."
The first surgery was performed by Dr. Franz F Birkholtz in South Africa
in November.
The TrueLok™ Hexapod System is planned to launch during the fourth
quarter 2012 in certain international markets and is on display this
week at the annual meetings of the Italian Society of Orthopaedics and
Traumatology (SIOT) in Rome, Italy and the French Society of Orthopedic
Surgery and Traumatology (SOFCOT) in Paris, France.
About Orthofix:
Orthofix International N.V. is a diversified, global medical device
company focused on developing and delivering innovative repair and
regenerative solutions to the spine and orthopedic markets. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
and via collaborations with other leading orthopedic product companies.
In addition, Orthofix is collaborating on R&D activities with leading
research and clinical organizations such as the Musculoskeletal
Transplant Foundation, the Orthopedic Research and Education Foundation,
and Texas Scottish Rite Hospital for Children. For more information
about Orthofix, please visit www.orthofix.com.
About Texas Scottish Rite Hospital for Children:
Texas Scottish Rite Hospital for Children is one of the nation's leading
pediatric centers for the treatment of orthopedic conditions, certain
related neurological disorders and learning disorders, such as dyslexia.
Admission is open to Texas children from birth up to 18 years of age.
Patients receive treatment regardless of the family's ability to pay.
For more information, to volunteer or to make a donation, please call
(214) 559-5000 or (800) 421-1121 or visit www.tsrhc.org.
Orthofix International N.V.
Mark Quick, 214-937-2924
Director
of Investor Relations and Business Development
markquick@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media